https://sputniknews.in/20260811/11920105.html
Russian Scientists Develop New Treatment for Drug-Induced Rhinitis
Russian Scientists Develop New Treatment for Drug-Induced Rhinitis
Sputnik India
An intranasal spray for medication-induced rhinitis, often caused by prolonged overuse of decongestant sprays, has been developed by Russian scientists at... 11.08.2026, Sputnik India
2026-08-11T15:38+0530
2026-08-11T15:38+0530
2026-08-11T15:42+0530
science & tech
health
russia
science & tech
https://cdn1.img.sputniknews.in/img/07ea/08/0b/11920269_0:164:3059:1885_1920x0_80_0_0_ebd3d26468b83d948c1da84154ececac.jpg
Its key feature is a mucoadhesive component that keeps the active ingredient on the nasal lining longer, prolonging the therapeutic effect while reducing the risk of systemic side effects. The university says there are currently no equivalent products on the Russian or international markets.The spray has entered preclinical testing, with pilot studies on rats and rabbits confirming its safety and effectiveness. The developers have also filed a patent application with Rospatent.
russia
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2026
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_IN
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
https://cdn1.img.sputniknews.in/img/07ea/08/0b/11920269_164:0:2895:2048_1920x0_80_0_0_abd02b7493718073e854df4a04547450.jpgSputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
health, russia, science & tech
health, russia, science & tech
Russian Scientists Develop New Treatment for Drug-Induced Rhinitis
15:38 11.08.2026 (Updated: 15:42 11.08.2026) An intranasal spray for medication-induced rhinitis, often caused by prolonged overuse of decongestant sprays, has been developed by Russian scientists at Sechenov University.
Its key feature is a mucoadhesive component that keeps the active ingredient on the nasal lining longer, prolonging the therapeutic effect while reducing the risk of systemic side effects. The university says there are currently no equivalent products on the Russian or international markets.
The spray has entered preclinical testing, with pilot studies on rats and rabbits confirming its safety and effectiveness. The developers have also filed a patent application with Rospatent.